Siga E, Champigneulle A, Imbert-Teboul M
Laboratoire de Physiologie Cellulaire, Collège de France, Paris.
Am J Physiol. 1994 Sep;267(3 Pt 2):F354-65. doi: 10.1152/ajprenal.1994.267.3.F354.
Fura 2 fluorescence measurements were carried out on microperfused rat cortical collecting ducts (CCD) to investigate the effect of adenosine 3',5'-cyclic monophosphate (cAMP) and adenylate cyclase-stimulating hormones on free cytosolic calcium ([Ca2+]i). Forskolin, 3-isobutyl-1-methylxanthine, and 8-(4-chlorophenylthio)-cAMP (CPT-cAMP) all triggered marked and sustained [Ca2+]i variations. Maximal increases elicited by 100 microM CPT-cAMP amounted to 101 +/- 11 nM (mean +/- SE, n = 18). This effect was mostly dependent on the presence of basolateral calcium and totally independent of luminal calcium. It remained unchanged in CCD perfused with sodium-free luminal fluid (82 +/- 10 nM, n = 5), pretreated with 1 mM bath ouabain (113 +/- 20, n = 4), or superfused with sodium-free bath in the presence of ouabain (82 +/- 22, n = 5). The V2 agonist 1-desamino-8-D-arginine vasopressin (DDAVP, 10 nM) increased [Ca2+]i by 57 +/- 5 nM (n = 27), a value 40% lower than that achieved with 10 nM AVP (141 +/- 7, n = 34) but similar to that observed with AVP + a V1a antagonist (57 +/- 6, n = 6). Significant effects could also be obtained with 200 pM DDAVP (31 +/- 6, n = 8) and arginine vasopressin (AVP) (72 +/- 6, n = 16). Rat calcitonin also raised [Ca2+]i by 43 +/- 10 (n = 8) and 66 +/- 8 nM (n = 17) at 1 and 10 nM, respectively, and its effect was not additive to that of CPT-cAMP. Calcitonin and DDAVP effects, like those of CPT-cAMP and forskolin, were nearly abolished in Ca(2+)-free bath, but AVP action on intracellular release persisted. These results show that, in rat CCD, cAMP effects on [Ca2+]i mainly result from basolateral calcium entry. In contrast to rabbit CCD the mechanism is independent on Na reabsorption and basolateral Na+/Ca2+ exchange. Calcitonin and DDAVP effects on [Ca2+]i are probably secondary to increased cAMP production.
在微灌注的大鼠皮质集合管(CCD)上进行了Fura 2荧光测量,以研究3',5'-环磷酸腺苷(cAMP)和腺苷酸环化酶刺激激素对游离胞质钙([Ca2+]i)的影响。福斯可林、3-异丁基-1-甲基黄嘌呤和8-(4-氯苯基硫代)-cAMP(CPT-cAMP)均引发了显著且持续的[Ca2+]i变化。100 microM CPT-cAMP引起的最大增加量达101±11 nM(平均值±标准误,n = 18)。这种效应主要依赖于基底外侧钙的存在,且完全独立于管腔钙。在用无钠管腔液灌注的CCD中(82±10 nM,n = 5)、用1 mM浴乌本苷预处理后(113±20,n = 4)或在乌本苷存在下用无钠浴液 superfused 时(82±22,n = 5),该效应保持不变。V2激动剂1-去氨基-8-D-精氨酸加压素(DDAVP,10 nM)使[Ca2+]i增加57±5 nM(n = 27),该值比10 nM AVP所达到的值低40%(141±7,n = 34),但与用AVP + V1a拮抗剂观察到的值相似(57±6,n = 6)。200 pM DDAVP(31±6,n = 8)和精氨酸加压素(AVP)(72±6,n = 16)也能产生显著效应。大鼠降钙素在1 nM和10 nM时分别使[Ca2+]i升高43±10(n = 8)和66±8 nM(n = 17),其效应与CPT-cAMP的效应无相加性。降钙素和DDAVP的效应,与CPT-cAMP和福斯可林的效应一样,在无钙浴中几乎被消除,但AVP对细胞内释放的作用持续存在。这些结果表明,在大鼠CCD中,cAMP对[Ca2+]i的影响主要源于基底外侧钙的内流。与兔CCD不同,其机制独立于钠重吸收和基底外侧Na+/Ca2+交换。降钙素和DDAVP对[Ca2+]i的影响可能继发于cAMP生成的增加。